Synthesis, biological evaluation and computational studies of novel iminothiazolidinone benzenesulfonamides as potent carbonic anhydrase II and IX inhibitors

被引：28
|
作者：
Mahmood, Shams-ul [1 ]
Saeed, Aamer [1 ]
Bua, Sivia [2 ]
Nocentini, Alessio [2 ,3 ,4 ]
Gratteri, Paola [3 ,4 ]
Supuran, Claudiu T. [2 ]
机构：
[1] Quaid I Azam Univ, Dept Chem, Islamabad 45320, Pakistan
[2] Univ Florence, Dept NEUROFARBA, Pharmaceut & Nutraceut Sect, Via Ugo Schiff 6, I-50019 Florence, Italy
[3] Univ Florence, Dept NEUROFARBA, Sect Pharmaceut & Nutraceut Sci, Lab Mol Modeling Cheminformat,Pole Sci, Via U Schiff 6, I-50019 Florence, Italy
[4] Univ Florence, QSAR, Polo Sci, Via U Schiff 6, I-50019 Florence, Italy
来源：
BIOORGANIC CHEMISTRY | 2018年 / 77卷
关键词：
Carbonic anhydrase; Zinc-binding group; Nanomolar inhibition; Anti-glaucoma; Anti-tumour; ANTICANCER AGENTS; DESIGN; SULFONAMIDES; MOIETIES; DRUG; DERIVATIVES; ACTIVATORS; DISCOVERY; CANCER; BASES;
D O I：
10.1016/j.bioorg.2018.01.031
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
A series of iminothiazolidinone-sulfonamide hybrids (2a-k) was synthesized by heterocyclization of sulfanilamide thioureas with methyl bromoacetate and characterized by spectroscopic techniques, mass and elemental analysis. The synthesized derivatives were screened against four relevant human (h) isoforms of carbonic anydrases (CAs, EC 4.2.1.1) I, II, IV and IX. These enzymes are involved in a variety of diseases, including glaucoma, retinitis pigmentosa, epilepsy, arthritis, and tumors. Derivatives 2a-2k exhibited the best inhibitory activity against the cytosolyc hCA II (Kis are reaching the sub-nanomolar range, 0.41-37.8 nM) and against the tumor-associated isoform hCA IX (Kis are spanning between 24.3 and 368.3 nM). The binding mode of the reported iminothiazolidinone benzenesulfonamides within hCA II and IX catalytic clefts was investigated by docking studies. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码：381 / 386
页数：6
相关论文
共 50 条
  • [31] Synthesis, biological evaluation and in silico studies of novel N-substituted phthalazine sulfonamide compounds as potent carbonic anhydrase and acetylcholinesterase inhibitors
    Turkes, Cuneyt
    Arslan, Mustafa
    Demir, Yeliz
    Cocaj, Liridon
    Nixha, Arleta Rifati
    Beydemir, Sukru
    BIOORGANIC CHEMISTRY, 2019, 89
  • [32] Synthesis and biological evaluation of sulfamate derivatives as inhibitors of carbonic anhydrases II and IX
    Jalil, Saquib
    Ullah, Saif
    Zaraei, Seyed-Omar
    Sbenati, Rawan M.
    Shahin, Afnan I.
    AlKubaisi, Bilal O.
    Pelletier, Julie
    Sevigny, Jean
    Al-Tel, Taleb H.
    Iqbal, Jamshed
    El-Gamal, Mohammed I.
    MEDICINAL CHEMISTRY RESEARCH, 2023, 32 (05) : 869 - 883
  • [33] Synthesis and biological evaluation of sulfamate derivatives as inhibitors of carbonic anhydrases II and IX
    Saquib Jalil
    Saif Ullah
    Seyed-Omar Zaraei
    Rawan M. Sbenati
    Afnan I. Shahin
    Bilal O. AlKubaisi
    Julie Pelletier
    Jean Sévigny
    Taleb H. Al-Tel
    Jamshed Iqbal
    Mohammed I. El-Gamal
    Medicinal Chemistry Research, 2023, 32 : 869 - 883
  • [34] 4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX Inhibitors
    Salerno, Silvia
    Barresi, Elisabetta
    Amendola, Giorgio
    Berrino, Emanuela
    Milite, Ciro
    Marini, Anna Maria
    Da Settimo, Federico
    Novellino, Ettore
    Supuran, Claudiu T.
    Cosconati, Sandro
    Taliani, Sabrina
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (13) : 5765 - 5770
  • [35] Synthesis and inhibition potency of novel ureido benzenesulfonamides incorporating GABA as tumor-associated carbonic anhydrase IX and XII inhibitors
    Ceruso, Mariangela
    Antel, Sabrina
    Scozzafava, Andrea
    Supuran, Claudiu T.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 (02) : 205 - 211
  • [36] Synthesis of novel acyl selenoureido benzensulfonamides as carbonic anhydrase I, II, VII and IX inhibitors
    Angeli, Andrea
    Carta, Fabrizio
    Bartolucci, Gianluca
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (13) : 3567 - 3573
  • [37] Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Tri-Aryl Imidazole-Benzene Sulfonamide Hybrids as Promising Selective Carbonic Anhydrase IX and XII Inhibitors
    Al-Wahaibi, Lamya H.
    Youssif, Bahaa G. M.
    Taher, Ehab S.
    Abdelazeem, Ahmed H.
    Abdelhamid, Antar A.
    Marzouk, Adel A.
    MOLECULES, 2021, 26 (16):
  • [38] Design and Synthesis of 3-(Phenylsulfonamido)benzamide Derivatives as Potent Carbonic Anhydrase IX Inhibitors: Biological Evaluations and Molecular Modeling Studies
    Khanfar, Mohammad A.
    Saleh, Mohammad
    MEDICINAL CHEMISTRY, 2025, 21 (02) : 160 - 167
  • [39] Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors
    Buza, Aida
    Turkes, Cuneyt
    Arslan, Mustafa
    Demir, Yeliz
    Dincer, Busra
    Nixha, Arleta Rifati
    Beydemir, Sukru
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2023, 239
  • [40] Synthesis, biological and molecular dynamics investigations with a series of triazolopyrimidine/triazole-based benzenesulfonamides as novel carbonic anhydrase inhibitors
    Said, Mohamed A.
    Eldehna, Wagdy M.
    Nocentini, Alessi
    Bonardi, Alessandro
    Fahim, Samar H.
    Bua, Silvia
    Soliman, Dalia H.
    Abdel-Aziz, Hatem A.
    Gratteri, Paola
    Abou-Seri, Sahar M.
    Supuran, Claudiu T.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 185
12345